Literature DB >> 29943139

Sarcopenic Obesity Is Associated with Severe Postoperative Complications in Gastric Cancer Patients Undergoing Gastrectomy: a Prospective Study.

Wei-Teng Zhang1, Ji Lin1, Wei-Sheng Chen1, Yun-Shi Huang1, Rui-Sen Wu1, Xiao-Dong Chen1, Neng Lou1, Chu-Huai Chi1, Chang-Yuan Hu2, Xian Shen3,4.   

Abstract

OBJECTIVE: This study aimed to determine the risk of severe postoperative complications (SPCs) in patients with gastric cancer and to construct a nomogram based on independently related factors to identify high-risk patients.
METHODS: We conducted a prospective study of 636 consecutive patients with gastric cancer who underwent radical gastrectomy. Degrees of sarcopenia and obesity were calculated before surgery. Factors contributing to SPCs were determined using univariate and multivariate analysis. A nomogram consisting of the independent risk factors was constructed to quantify the individual risk of SPCs.
RESULTS: Logistic analysis revealed that sarcopenic obesity, age, open surgery, and combined resection were independent prognostic factors for SPCs. Sarcopenic obese patients have the highest risk in all patients (sarcopenic obesity vs normal, OR = 6.575 p = 0.001; sarcopenic obesity vs obesity, OR = 5.833 p = 0.001; sarcopenic obesity vs sarcopenia, OR = 2.571 p = 0.032), while obese patients share the similar rate of SPCs with normal people (obesity vs normal, OR = 1.056 p = 0.723). The nomogram we constructed was able to quantify the risk of SPCs reliably (c-index, 0.737).
CONCLUSIONS: Sarcopenic obesity, together with age, open surgery, and combined resection are independent predictors of SPCs. Obesity will significantly increase the risk of SPCs in sarcopenic patient with gastric cancer, but it will not bring higher risk to normal patients. Our nomogram is a simple and practical instrument to identify patients at high risk of surgical complications.

Entities:  

Keywords:  Gastric cancer; Obesity; Postoperative complications; Sarcopenia

Mesh:

Year:  2018        PMID: 29943139     DOI: 10.1007/s11605-018-3835-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  37 in total

1.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

Review 2.  Nomograms in oncology: more than meets the eye.

Authors:  Vinod P Balachandran; Mithat Gonen; J Joshua Smith; Ronald P DeMatteo
Journal:  Lancet Oncol       Date:  2015-04       Impact factor: 41.316

3.  Identification of frequency, severity and risk factors of complications after open gastrectomy: Retrospective analysis of prospectively collected database using the Clavien-Dindo classification.

Authors:  Masatoshi Nakagawa; Kazuyuki Kojima; Mikito Inokuchi; Keiji Kato; Hirofumi Sugita; Sho Otsuki; Kenichi Sugihara
Journal:  J Med Dent Sci       Date:  2016

Review 4.  Organ physiology of aging.

Authors:  B M Evers; C M Townsend; J C Thompson
Journal:  Surg Clin North Am       Date:  1994-02       Impact factor: 2.741

5.  Impact of body mass index on the short-term outcomes of resected gastrointestinal stromal tumors.

Authors:  Zachary E Stiles; Tyler M Rist; Paxton V Dickson; Evan S Glazer; Martin D Fleming; David Shibata; Jeremiah L Deneve
Journal:  J Surg Res       Date:  2017-05-10       Impact factor: 2.192

6.  Effectiveness of a preoperative exercise and nutritional support program for elderly sarcopenic patients with gastric cancer.

Authors:  Kazuyoshi Yamamoto; Yukiko Nagatsuma; Yasunari Fukuda; Motohiro Hirao; Kazuhiro Nishikawa; Atsushi Miyamoto; Masataka Ikeda; Shoji Nakamori; Mitsugu Sekimoto; Kazumasa Fujitani; Toshimasa Tsujinaka
Journal:  Gastric Cancer       Date:  2016-12-28       Impact factor: 7.370

7.  Role of obesity and abdominal shape morphometric features to predict postoperative complications and quality of lymph node dissection of gastrectomy for gastric cancer.

Authors:  M HasbahcecI; E MehdI; F U Malya; E Kunduz; N MemmI; S YIgman; A Akcakaya
Journal:  Neoplasma       Date:  2017       Impact factor: 2.575

8.  Influence of obesity on complications and costs after intestinal surgery.

Authors:  Heather Wakefield; Mary Vaughan-Sarrazin; Joseph J Cullen
Journal:  Am J Surg       Date:  2012-05-09       Impact factor: 2.565

9.  The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia.

Authors:  R Dallmann; P Weyermann; C Anklin; M Boroff; K Bray-French; B Cardel; I Courdier-Fruh; H Deppe; J Dubach-Powell; M Erb; R H Haefeli; M Henneböhle; H Herzner; M Hufschmid; D L Marks; S Nordhoff; M Papp; C Rummey; G Santos; F Schärer; H Siendt; M Soeberdt; L T Sumanovski; M Terinek; C Mondadori; N Güven; A Feurer
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-08-28       Impact factor: 12.910

10.  Population health and regional variations of disease burden in Japan, 1990-2015: a systematic subnational analysis for the Global Burden of Disease Study 2015.

Authors:  Shuhei Nomura; Haruka Sakamoto; Scott Glenn; Yusuke Tsugawa; Sarah K Abe; Md M Rahman; Jonathan C Brown; Satoshi Ezoe; Christina Fitzmaurice; Tsuyoshi Inokuchi; Nicholas J Kassebaum; Norito Kawakami; Yosuke Kita; Naoki Kondo; Stephen S Lim; Satoshi Maruyama; Hiroaki Miyata; Meghan D Mooney; Mohsen Naghavi; Tomoko Onoda; Erika Ota; Yuji Otake; Gregory A Roth; Eiko Saito; Takahiro Tabuchi; Yohsuke Takasaki; Tadayuki Tanimura; Manami Uechi; Theo Vos; Haidong Wang; Manami Inoue; Christopher J L Murray; Kenji Shibuya
Journal:  Lancet       Date:  2017-07-19       Impact factor: 79.321

View more
  9 in total

1.  Is Sarcopenic Obesity an Indicator of Poor Prognosis in Gastric Cancer Surgery? A Cohort Study in a Western Population.

Authors:  V Rodrigues; F Landi; S Castro; R Mast; N Rodríguez; A Gantxegi; J Pradell; M López-Cano; M Armengol
Journal:  J Gastrointest Surg       Date:  2020-07-13       Impact factor: 3.452

2.  CT evaluated sarcopenia signals: Shorter survival for small cell lung cancer patients.

Authors:  A Pekařová; M Pekař; D Daniš; Z Nováková
Journal:  Physiol Res       Date:  2021-12-31       Impact factor: 1.881

Review 3.  The Role of Sarcopenic Obesity in Cancer and Cardiovascular Disease: A Synthesis of the Evidence on Pathophysiological Aspects and Clinical Implications.

Authors:  Erika Aparecida Silveira; Rômulo Roosevelt da Silva Filho; Maria Claudia Bernardes Spexoto; Fahimeh Haghighatdoost; Nizal Sarrafzadegan; Cesar de Oliveira
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

4.  Psoas density - an optimal sarcopaenic indicator associated with postoperative complications after colorectal resection for cancer?

Authors:  Anna Pekařová; Matej Pekař; Marek Soltes; Lucia Havrlentová; Tereza Chovancová
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2020-11-13       Impact factor: 1.195

Review 5.  Sarcopenia in Children with Solid Organ Tumors: An Instrumental Era.

Authors:  Annika Ritz; Eberhard Lurz; Michael Berger
Journal:  Cells       Date:  2022-04-09       Impact factor: 7.666

6.  Sarcopenic obesity and therapeutic outcomes in gastrointestinal surgical oncology: A meta-analysis.

Authors:  Peiyu Wang; Shaodong Wang; Yi Ma; Haoran Li; Zheng Liu; Guihu Lin; Xiao Li; Fan Yang; Mantang Qiu
Journal:  Front Nutr       Date:  2022-07-22

7.  Detection of sarcopenic obesity and prediction of long-term survival in patients with gastric cancer using preoperative computed tomography and machine learning.

Authors:  Jaehyuk Kim; Seung Hee Han; Hyoung-Il Kim
Journal:  J Surg Oncol       Date:  2021-09-07       Impact factor: 2.885

8.  CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis.

Authors:  Huaiying Su; Junxian Ruan; Tianfeng Chen; Enyi Lin; Lijing Shi
Journal:  Cancer Imaging       Date:  2019-12-03       Impact factor: 3.909

9.  Preoperative Sedentary Time Predicts Postoperative Complications in Gastrointestinal Cancer.

Authors:  Takuya Yanagisawa; Hideshi Sugiura; Noriatsu Tatematsu; Mioko Horiuchi; Saki Migitaka; Keita Itatsu
Journal:  Asian Pac J Cancer Prev       Date:  2020-11-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.